AKI within 48โ72h of iodinated contrast exposure. Rise in Cr โฅ 0.3 mg/dL or โฅ 50% from baseline. Risk factors: CKD, diabetes, dehydration, high contrast volume. Prevention: IV NS hydration before and after contrast.
๐ Overview
Definition & Risk Factors
Contrast-induced nephropathy (CIN) or contrast-associated AKI: rise in serum creatinine โฅ 0.3 mg/dL or โฅ 50% from baseline within 48โ72 hours of iodinated contrast administration.
Risk Factor
Details
CKD (eGFR < 30)
#1 risk factor. Risk is very low with eGFR > 45.
Diabetes + CKD
Combined = highest risk. Diabetes alone (without CKD) is NOT a significant risk factor.
Volume depletion
Dehydration concentrates contrast in kidneys โ direct tubular toxicity
High contrast volume
Risk proportional to volume. Minimize contrast used.
Nephrotoxic medications
NSAIDs, aminoglycosides, ACEi/ARBs (hold if possible day of contrast)
Heart failure
Reduced renal perfusion
Risk of CIN has been overestimated. Recent large studies suggest true contrast-induced AKI is much less common than previously thought, especially with IV contrast (vs intra-arterial). Do NOT withhold indicated CT scans for fear of CIN -delayed diagnosis is often more dangerous.
Pathophysiology
Direct tubular toxicity, osmotic injury to renal tubular epithelial cells from hyperosmolar contrast
Renal vasoconstriction โ medullary ischemia, outer medulla is a vulnerable watershed zone with baseline low oxygen tension; contrast exacerbates ischemia
Reactive oxygen species (ROS), contrast generates free radicals โ oxidative injury to tubular cells
Important caveat: Recent evidence suggests much of what was historically attributed to "CIN" was actually coincidental AKI in sick hospitalized patients. True causes in many cases: cholesterol emboli (especially after cardiac cath), hemodynamic changes, sepsis, nephrotoxic medications. The term "contrast-associated AKI" (CA-AKI) is preferred over "CIN" to reflect this uncertainty.
IV vs Intra-arterial Contrast
Route
Risk
Notes
IV contrast (CT scans)
Very low risk of true CIN, even in CKD
Multiple large propensity-matched studies show minimal additional AKI risk beyond what would occur without contrast. Do NOT withhold indicated CT scans.
Contrast delivered directly to renal arteries at high concentration. This is where most true CIN occurs. Volume of contrast is the key modifiable risk factor.
Updated Practice: The risk of IV contrast-induced AKI has been significantly overestimated. AMACING, 2017 showed that in patients with eGFR 30โ59, prophylactic IV hydration provided NO benefit over no prevention. PRESERVE, 2018 showed bicarb is not superior to NS, and NAC is not beneficial. Current radiology guidelines state: do not withhold indicated contrast CT scans in patients with AKI or CKD. Delayed diagnosis from avoiding imaging is often more harmful than the small risk of CIN.
๐จ Management
Prevention Protocol
IV isotonic saline -1 mL/kg/hr for 6โ12h before AND 6โ12h after contrast. #1 proven prevention.
Hold nephrotoxins -NSAIDs, aminoglycosides. Consider holding ACEi/ARB day of contrast.
Metformin:Updated (ACR 2022): If eGFR โฅ 45, no need to hold. If eGFR 30โ44, hold day of contrast, resume 48h later if Cr stable. eGFR < 30, hold regardless. Risk is lactic acidosis if contrast causes AKI โ metformin accumulates. Old blanket "hold metformin for all contrast" is outdated.
Use low-osmolar or iso-osmolar contrast
N-acetylcysteine -no longer recommended (multiple trials show no benefit)
Avoid repeat contrast within 48โ72h if possible
KDIGO-based CIN Prevention Protocol
eGFR
Risk Level
Pre-Procedure Protocol
eGFR > 45
Low risk
Routine hydration. No special precautions needed.
eGFR 30โ45
Moderate risk
IV NS 1 mL/kg/hr ร 6โ12h before contrast
eGFR < 30
High risk
IV NS 1 mL/kg/hr ร 6โ12h before AND after contrast. Minimize contrast volume. Consider alternative imaging if appropriate.
Emergency Situations
Do NOT delay emergent imaging for hydration. In life-threatening situations (PE, aortic dissection, stroke, trauma), proceed with contrast CT immediately.
If time allows: Give a bolus of NS 3 mL/kg over 1h before contrast, then continue hydration post-procedure.
CIN, if it occurs, is usually self-limited. A missed diagnosis is not.
Hold Nephrotoxins
NSAIDs, hold before and after contrast
Aminoglycosides, hold if possible
ACEi/ARB, consider holding day of procedure (controversial but reasonable in high-risk patients)
๐งช Workup
Baseline creatinine + eGFR -assess risk
BMP at 48โ72h post-contrast -check for Cr rise
Urinalysis -muddy brown granular casts (ATN pattern)
Urine sodium -may be elevated (tubular injury)
Assess volume status -dehydration increases risk
๐ Medications
Intervention
Details
Evidence
IV NS
1 mL/kg/hr ร 6โ12h pre- and post-contrast
Best evidence for prevention. Only proven intervention.
IV NaHCOโ
3 mL/kg/hr ร 1h pre, then 1 mL/kg/hr ร 6h post
PRESERVE, 2018 showed NOT superior to NS. Use NS instead.
N-Acetylcysteine (Mucomyst)
600โ1200 mg PO BID ร 2 days
No longer recommended.ACT, 2011 and PRESERVE, 2018 showed no benefit.
Hold metformin
Hold 48h AFTER contrast
Prevents lactic acidosis if AKI develops. Resume when Cr stable.
๐ On Rounds
Pimp Questions
Should you hold a contrast CT in a patient with CKD and acute illness?
Generally no -do not withhold indicated imaging. The risk of CIN has been overestimated in observational studies (confounded by other causes of AKI in sick patients). Multiple recent studies suggest true IV contrast-induced AKI is uncommon. Delayed or missed diagnosis from avoiding CT is often more dangerous than the small risk of CIN. Hydrate, minimize contrast volume, and proceed with the study if clinically indicated.
Why was N-acetylcysteine (NAC) removed from CIN prevention protocols?
NAC was widely used for decades based on small, conflicting studies. ACT, 2011 and PRESERVE, 2018 definitively showed that NAC provides no benefit over IV saline alone for preventing CIN. Furthermore, NAC may cause a spurious decrease in creatinine (analytically interferes with the assay), giving a false impression of renal protection. Current guidelines recommend IV hydration only.
๐ Case 1, CKD Patient Needing Contrast CT
Patient: 72M with CKD stage 3b (eGFR 38), diabetes. Needs CT abdomen/pelvis for suspected diverticular abscess. Team wants to avoid contrast.
Recommendation: Proceed with contrast CT.
eGFR 38 = low-moderate risk for CIN
IV NS 1 mL/kg/hr ร 6h before and after contrast
Hold metformin 48h after contrast
Missing an abscess that needs drainage is worse than CIN risk
Key lesson: Do not withhold indicated contrast imaging in CKD patients. Hydrate appropriately and proceed.
๐ Case 2, Post-Cardiac Cath AKI
Patient: 55F post-cardiac catheterization (200 mL contrast), eGFR 25, diabetes. Cr was 2.1 pre-cath, now 2.8 at 48h. UOP decreasing.
Diagnosis: Contrast-associated AKI (intra-arterial route, high risk).
Management:
Aggressive IV hydration (monitor for volume overload)
Hold all nephrotoxins
Monitor Cr daily
Most cases self-resolve in 7โ14 days
Dialysis rarely needed
Key lesson: Intra-arterial contrast (cardiac cath) carries higher CIN risk than IV contrast. High contrast volume + low baseline eGFR = highest risk combination.
๐ Case 3, Emergent CT-PE with Elevated Creatinine
Patient: 40F in ED with acute dyspnea, tachycardia, pleuritic chest pain. Wells score 6 (PE likely). eGFR unknown but Cr was 1.8 last year.
Intern asks: Should we wait for today's Cr before ordering CT-PE?
Answer: NO. Emergent CT-PE now.
A missed PE can be fatal
CIN risk is low with IV contrast
Give concurrent NS bolus while patient is in CT
Do NOT delay life-saving imaging for CIN prevention
Key lesson: In emergent situations, the risk of a missed diagnosis always outweighs the risk of CIN. Proceed with imaging and hydrate concurrently.
โก Summary
#1 Risk Factor
CKD (eGFR < 30). Diabetes + CKD = highest risk. DM alone is NOT significant risk.
Prevention
IV NS 1 mL/kg/hr ร 6-12h before and after. Only proven intervention.
NAC
No longer recommended. ACT, 2011 and PRESERVE, 2018 showed no benefit over NS alone.
Metformin
Hold 48h AFTER contrast (not before). Resume when Cr stable. Risk: lactic acidosis if AKI.
Don't Delay
CIN risk is overestimated. Do NOT withhold indicated imaging -missed diagnosis is more dangerous.
Course
Self-limited. Cr peaks day 3-5, returns to baseline 7-14 days. Rarely needs dialysis.